Dror Bashan
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Dror Bashan is currently President, Chief Executive Officer & Director at Protalix Biotherapeutics, Inc. since 2019.
Formerly, Mr. Bashan was Senior VP-Global Business Development at Teva Pharmaceutical Industries Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2026 | 2.532.934 ( 3,14% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Algemeen Directeur | 30-06-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau